Veronica Mullin LCADC LCSW

Veronica Mullin LCADC LCSW, based in Matawan, NJ, is one of the SAMHSA-registered treatment programs operating in NJ. The facility's programming is outpatient (IOP, Dual Dx), not residential. What this page can help with is the frame — what to ask, what to verify, what to compare against.

Care levels at Veronica Mullin LCADC LCSW

The care-level question matters because what a facility offers is what it can realistically treat well. Veronica Mullin LCADC LCSW is an outpatient-focused program (IOP, Dual Dx) — patients live at home or in sober living and attend treatment sessions. This level of care is clinically appropriate for mild-to-moderate substance use disorder, or for patients stepping down from residential. Before admission, an independent clinical assessment (from a primary-care doctor, licensed substance-use counselor, or addiction-medicine physician) can confirm whether Veronica Mullin LCADC LCSW's offerings match the clinical need.

Insurance and payment

On insurance specifically: Veronica Mullin LCADC LCSW operates primarily on commercial insurance. The implication for patients: higher typical cost-share, potentially more intensive programming, and the full burden of MHPAEA parity-rule dynamics — including appeal rights when the plan denies. Before admission, ask the facility's utilization-review team for a written Verification of Benefits — not verbal assurance, which is where most post-treatment financial surprises come from. Also ask for specific plan-level confirmation, not carrier-level (e.g., "your Aetna PPO plan" not just "Aetna").

Specialty programming

The facility's documented specialty programming includes: Adolescents, Young adults, Adult women. If that matches what you or your family member need, great — and worth asking specifically about what the programming looks like day-to-day (how many hours per week of specialty-specific content, who leads it, what credentials they hold).

Before you call

Before admission to Veronica Mullin LCADC LCSW, three questions consistently produce the most useful information: (1) which ASAM level of care are you treating me at, and what is the clinical rationale; (2) can you send me a written Verification of Benefits for my specific insurance plan; (3) what is your policy on medication-assisted treatment for opioid use disorder — specifically, do you continue patients on buprenorphine or methadone during residential programming. If the clinical situation involves opioid use disorder, confirm explicitly whether Veronica Mullin LCADC LCSW offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care.